MUSTANG BIO
Mustang Bio is a clinical-stage biopharmaceutical company focused on the acquisition, development, and commercialization of novel cancer immunotherapy products designed to utilize the power of the patient's own immune system to eliminate cancer cells. The products under development are - CD123, CD20, and CS1.
MUSTANG BIO
Industry:
Biotechnology Pharmaceutical
Founded:
2015-01-01
Address:
New York, New York, United States
Country:
United States
Website Url:
http://www.mustangbio.com
Total Employee:
51+
Status:
Active
Contact:
(781)652-4500
Email Addresses:
[email protected]
Total Funding:
204.3 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Font API Google Analytics LetsEncrypt Google Tag Manager WordPress Google Universal Analytics
Similar Organizations
Arbutus Biopharma
Arbutus Biopharma Corporation is a publicly-traded biopharmaceutical company.
Sio Gene Therapies
Sio Gene Therapies is a clinical-stage biopharmaceutical company.
Caladrius Biosciences
Caladrius Biosciences is a clinical-stage biopharmaceutical company.
Context Therapeutics
Context Therapeutics is a clinical-stage biopharmaceutical company.
Corvus Pharmaceuticals
Corvus Pharmaceuticals is a clinical-stage biopharmaceutical company.
Cyclerion Therapeutics
Cyclerion Therapeutics is a clinical-stage biopharmaceutical company.
Frontier Biotechnologies
Frontier Biotechnologies is a commercial-stage bio-pharmaceutical company.
Leap Therapeutics
Leap Therapeutics is a clinical-stage biopharmaceutical company.
Mainz Biomed
Mainz BioMed molecular genetic diagnostics company.
Molecular Partners
Molecular Partners is a clinical-stage biopharmaceutical company.
Ocugen
Ocugen is a clinical stage biopharmaceutical company.
Current Employees Featured
Founder
Stock Details
Investors List
Runway Growth Capital
Runway Growth Capital investment in Post-IPO Debt - Mustang Bio
National Institutes of Health
National Institutes of Health investment in Grant - Mustang Bio
Horizon Technology Finance
Horizon Technology Finance investment in Post-IPO Debt - Mustang Bio
California Institute of Regenerative Medicine (CIRM)
California Institute of Regenerative Medicine (CIRM) investment in Grant - Mustang Bio
Official Site Inspections
http://www.mustangbio.com Semrush global rank: 342.55 K Semrush visits lastest month: 175.04 K
- Host name: cust-155.130.138.21.switch.com
- IP address: 155.130.138.21
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
More informations about "Mustang Bio"
MustangBio
Our world class team in-licenses, develops and manufactures next generation therapies for the ultimate benefit of patients.See details»
Mustang Bio, Inc. (MBIO)
Jun 21, 2024 · Mustang Bio, Inc. (“Mustang”) is a clinical-stage biopharmaceutical company focused on translating today’s medical breakthroughs in cell therapies into potential cures for difficult-to-treat cancers.See details»
Company Information :: Mustang Bio, Inc. (MBIO)
Mustang Bio, Inc. (“Mustang”) is a clinical-stage biopharmaceutical company focused on translating today’s medical breakthroughs in cell therapies into potential cures for difficult-to-treat cancers.See details»
About Mustang Bio – MustangBio
Recent medical breakthroughs in cell and gene therapy have signaled a coming revolution in patient care for previously untreatable disease. We at Mustang Bio are translating these breakthroughs into next-generation therapies for …See details»
Leadership - MustangBio
Dr. Litchman has served as President and Chief Executive Officer and has been a member of Mustang’s Board of Directors since April 2017. Litchman joined Mustang from Arvinas, LLC, …See details»
Mustang Bio - LinkedIn
Mustang Bio, Inc. (“Mustang”) is a clinical-stage bio-pharmaceutical company focused on translating today’s medical breakthroughs in cell and gene therapies into potential cures for hematologic...See details»
Mustang Bio - Wikipedia
Mustang Bio (Nasdaq: MBIO) is a clinical-stage biopharmaceutical company founded in 2015 and headquartered in Worcester, MA, U.S. [1][2][3] Operating as a partner company of Fortress …See details»
Mustang Bio Announces Amendment and Closing of …
Jul 31, 2023 · Mustang Bio, Inc. is a clinical-stage biopharmaceutical company focused on translating today’s medical breakthroughs in cell and gene therapies into potential cures for difficult-to-treat cancers and rare genetic diseases.See details»
Mustang Bio - Crunchbase Company Profile & Funding
Mustang Bio is a clinical-stage biopharmaceutical company focused on the acquisition, development, and commercialization of novel cancer immunotherapy products designed to utilize the power of the patient's own immune system to …See details»
Mustang Bio, Inc. (MBIO) - Yahoo Finance Canada
Mustang Bio, Inc., a clinical-stage biopharmaceutical company, focuses on translating medical breakthroughs in cell and gene therapies into potential cures for hematologic cancers, solid...See details»
Our Approach - MustangBio
At Mustang Bio, we partner with leading academic institutions, with the goal of delivering next generation therapies to patients in need worldwide. 377 Plantation Street • Worcester, MA 01605. 781-652-4500 [email protected]. © …See details»
Mustang Bio Announces Strategic Manufacturing Partnership and …
May 18, 2023 · uBriGene (Boston) Biosciences to acquire Mustang Bio’s Worcester manufacturing facility for total consideration of up to $11 million and enters into strategic …See details»
Mustang Bio Company Profile 2024: Stock Performance
Mustang Bio Inc is a clinical-stage biopharmaceutical company focused on translating today's medical breakthroughs in cell and gene therapy into potential cures for hematologic cancers, …See details»
Mustang Bio Announces Favorable Efficacy and Safety Data from …
WORCESTER, Mass., June 17, 2024 (GLOBE NEWSWIRE) -- Mustang Bio, Inc. (“Mustang” or the “Company”) (Nasdaq: MBIO), a clinical-stage biopharmaceutical company focused on …See details»
Mustang Bio Reports Full-Year 2022 Financial Results and Recent ...
Mar 29, 2023 · Mustang Bio, Inc. is a clinical-stage biopharmaceutical company focused on translating today’s medical breakthroughs in cell and gene therapies into potential cures for …See details»
Mustang Bio Announces FDA Acceptance of IND Application for
WORCHESTER, Mass., Oct. 26, 2023 (GLOBE NEWSWIRE) -- Mustang Bio, Inc. (“Mustang” or the “Company”) (Nasdaq: MBIO), a clinical-stage biopharmaceutical company focused on …See details»
Mustang Bio Announces $2.5 Million Registered Direct Offering …
Jun 20, 2024 · Mustang Bio, Inc. is a clinical-stage biopharmaceutical company focused on translating today’s medical breakthroughs in cell therapies into potential cures for difficult-to …See details»
Mustang Bio - Overview, News & Similar companies - ZoomInfo
May 22, 2024 · Mustang Bio contact info: Phone number: (781) 652-4500 Website: www.mustangbio.com What does Mustang Bio do? Mustang Bio, Inc. is a clinical-stage …See details»
Mustang Bio Announces Amendment and Closing of Strategic
Jul 31, 2023 · Mustang Bio, Inc. is a clinical-stage biopharmaceutical company focused on translating today’s medical breakthroughs in cell and gene therapies into potential cures for …See details»
Mustang Bio Receives Positive Listing Determination from Nasdaq
WORCESTER, Mass., Nov. 12, 2024 (GLOBE NEWSWIRE) -- Mustang Bio, Inc. (“Mustang” or the “Company”) (Nasdaq: MBIO), a clinical-stage biopharmaceutical company focused on …See details»